Company profile
Zomedica Corp. CIK 1684144
Ticker
ZOMDF (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Ann Arbor, MI 48108
Fiscal year end
2025 (FY)
Key Financials
Revenue
$32.03M
Net income
-$81.86M
Total assets
$127.04M
Total liabilities
$11.64M
Stockholders' equity
$115.40M
Cash & equivalents
$9.02M
Operating income
-$84.35M
Operating cash flow
-$17.65M
Capital expenditures
$567.0K
Fiscal year 2025, via 10-K filed 2026-03-16. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-263.4%
Net margin
-255.6%
Free cash flow
-$18.22M
Free cash flow margin
-56.9%
Liabilities / assets
9.2%
Equity / assets
90.8%
CapEx / revenue
1.8%
Operating cash flow / net income
0.22×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
$32.03M
-$81.86M
$127.04M
$11.64M
$115.40M
2024
$27.29M
-$46.98M
$207.36M
$11.70M
$195.66M
2023
$25.19M
-$34.53M
$253.20M
$13.18M
$240.02M
2022
$18.93M
-$17.02M
$279.61M
$12.22M
$267.39M
2021
$4.13M
-$18.38M
$280.40M
$9.51M
$270.89M
Company Details
SIC code
2834
State of incorporation
A0
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-07
Financials filed via
Form 10-K
filed 2026-03-16
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Ann Arbor, MI 48108
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:36 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.